Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Deficiency Diseases”

732 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 732 results

Large-scale testing (Phase 3)Study completedNCT00391131
What this trial is testing

Subcutaneous Ig NextGen 16% in PID Patients

Who this might be right for
Primary Immunodeficiency (PID)
CSL Limited 35
Testing effectiveness (Phase 2)Study completedNCT00267865
What this trial is testing

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

Who this might be right for
AIDS-Related-Primary Central Nervous System Lymphoma
National Cancer Institute (NCI) 12
Not applicableUnknownNCT01354587
What this trial is testing

Evaluation of Efficacy and Tolerability of Hizentra®

Who this might be right for
Primary Immunodeficiency Disorders
University of South Florida 50
Large-scale testing (Phase 3)Study completedNCT02269163
What this trial is testing

Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

Who this might be right for
Primary Immunodeficiency
Prometic Biotherapeutics, Inc. 82
Not applicableLooking for participantsNCT00055172
What this trial is testing

Genetic Basis of Immunodeficiency

Who this might be right for
Severe Combined Immunodeficiency
National Heart, Lung, and Blood Institute (NHLBI) 100
Not applicableStudy completedNCT04804072
What this trial is testing

INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit

Who this might be right for
HIV InfectionsDrug UseOpioid Use+1 more
HIV Prevention Trials Network 447
Testing effectiveness (Phase 2)Study completedNCT00176865
What this trial is testing

Stem Cell Transplant for Immunologic or Histiocytic Disorders

Who this might be right for
Hemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi Syndrome+3 more
Masonic Cancer Center, University of Minnesota 19
Not applicableStudy completedNCT01050465
What this trial is testing

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

Who this might be right for
Acne VulgarisAllergic RhinitisAnxiety+34 more
University of Missouri-Columbia 907
Large-scale testing (Phase 3)Study completedNCT00168012
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 42
Not applicableStudy completedNCT03029728
What this trial is testing

Biomarker for Hereditary AngioEdema Disease

Who this might be right for
C1 Esterase Inhibitor DeficiencyAngio EdemaC4 Deficiency+5 more
CENTOGENE GmbH Rostock 42
Large-scale testing (Phase 3)Study completedNCT02817451
What this trial is testing

DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 53
Large-scale testing (Phase 3)Looking for participantsNCT07298447
What this trial is testing

Donidalorsen Treatment in Children With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Ionis Pharmaceuticals, Inc. 20
Post-approval studies (Phase 4)UnknownNCT00124358
What this trial is testing

Buprenorphine and Integrated HIV Care Evaluation

Who this might be right for
Opioid-Related DisordersHIV InfectionsAIDS
The New York Academy of Medicine 1,350
Large-scale testing (Phase 3)Study completedNCT00462709
What this trial is testing

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 146
Testing effectiveness (Phase 2)Looking for participantsNCT07371663
What this trial is testing

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

Who this might be right for
Solid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more
Beijing Tide Pharmaceutical Co., Ltd 266
Testing effectiveness (Phase 2)Study completedNCT01826916
What this trial is testing

EDEMA2: Evaluation of DX-88's Effect in Mitigating Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 77
Not applicableNot Yet RecruitingNCT06519734
What this trial is testing

Primitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene Products

Who this might be right for
Primary Immune Deficiency Diseases
Assistance Publique - Hôpitaux de Paris 200
Not applicableStudy completedNCT03716700
What this trial is testing

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 126
Post-approval studies (Phase 4)Study completedNCT04566692
What this trial is testing

Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency

Who this might be right for
Primary Immunodeficiency
Grifols Therapeutics LLC 33
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Load More Results